Show side menu

TRANSVAC2: European Vaccine Research and Development Infrastructure

Starting date: 01/05/2017 End date: 30/04/2022
Programme: Animal health

TRANSVAC2 will support innovation for both prophylactic and therapeutic vaccine development based on a disease-overarching and one-health approach, thereby optimising the knowledge and expertise gained during the development of both human and animal vaccines